Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05407168 · ClinicalTrials.gov registry record · NA

Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool

A NA study of Lung Carcinoma, sponsored by OHSU Knight Cancer Institute.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
4
Study locations

NCT05407168 is a NA study of Lung Carcinoma that is actively recruiting participants, run by OHSU Knight Cancer Institute. The registered enrollment target is 300 participants, below the 5,036-participant average among 38 other Lung Carcinoma trials with a reported enrollment target (94% lower). The trial reports 4 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05407168, a NA study of Lung Carcinoma, is actively recruiting participants, sponsored by OHSU Knight Cancer Institute.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
4
Study locations

Study Summary

This clinical trial evaluates the effectiveness of a conversation tool on patient-centered health and decision-making outcomes in patients with lung cancer making treatment decisions. This research is being conducted to help doctors understand the information patients need to participate in shared decision-making about their lung cancer treatment options. The focus of this research is to study how patients choose lung cancer treatment options and the information needed to make that choice, with a focus on patients with lower health literacy.

Conditions Studied

Interventions

  • OTHER Questionnaire Administration
  • OTHER Best Practice
  • OTHER Health Promotion and Education

Study Locations (4)

Oregon

  • Hillsboro Medical Center - Hillsboro
  • Adventist Health Portland - Portland
  • OHSU Knight Cancer Institute - Portland
  • Portland VA Medical Center - Portland

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2022-10-31
Est. Completion 2027-12-31
Phase NA

Sponsor

OHSU Knight Cancer Institute

211 total trials

What the Registry Record Tells You About NCT05407168

The ClinicalTrials.gov registry entry for NCT05407168 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,036-participant average among 38 other Lung Carcinoma trials with a reported enrollment target (94% lower). The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.

NCT05407168 reports 4 study locations spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT05407168 about?

NCT05407168 is a clinical study titled "Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool". This clinical trial evaluates the effectiveness of a conversation tool on patient-centered health and decision-making outcomes in patients with lung cancer making treatment decisions. This research is being conducted to help doctors understand the information patients need to participate in shared d...

What is the current status of trial NCT05407168?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2022-10-31. Estimated completion is 2027-12-31.

What conditions does trial NCT05407168 study?

This clinical trial studies the following conditions: Lung Carcinoma.

What interventions are being tested in trial NCT05407168?

The interventions under investigation include: Questionnaire Administration (OTHER), Best Practice (OTHER), Health Promotion and Education (OTHER).

Who is sponsoring clinical trial NCT05407168?

This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05407168 being conducted?

This trial has 4 study locations across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.